M H Yu

526 total citations
15 papers, 111 citations indexed

About

M H Yu is a scholar working on Molecular Biology, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, M H Yu has authored 15 papers receiving a total of 111 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Obstetrics and Gynecology. Recurrent topics in M H Yu's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (2 papers) and Advanced Proteomics Techniques and Applications (2 papers). M H Yu is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (2 papers) and Advanced Proteomics Techniques and Applications (2 papers). M H Yu collaborates with scholars based in Taiwan, New Zealand and South Korea. M H Yu's co-authors include Steve R. Roffler, M Y Yeh, Tang‐Yuan Chu, Cheng‐Chang Chang, Chun‐Chi Chen, Bing‐Mae Chen, Ching‐Yu Lin, M.S. Kao, Cheng‐Ting Hsu and Kihwan Hwang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gynecologic Oncology and Histochemistry and Cell Biology.

In The Last Decade

M H Yu

15 papers receiving 110 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M H Yu Taiwan	8	51	28	20	19	18	15	111
Vladimir Nosov Russia	3	50 1.0×	29 1.0×	8 0.4×	87 4.6×	16 0.9×	6	134
Mehrad Mahmoudian Finland	7	54 1.1×	15 0.5×	10 0.5×	13 0.7×	13 0.7×	11	123
Haojie He China	6	80 1.6×	18 0.6×	11 0.6×	16 0.8×	19 1.1×	14	129
Ana Babić United States	7	39 0.8×	24 0.9×	11 0.6×	70 3.7×	26 1.4×	11	149
Steven Gay United States	5	125 2.5×	34 1.2×	9 0.5×	19 1.0×	3 0.2×	14	207
Evelyn Fleming United States	6	24 0.5×	15 0.5×	6 0.3×	56 2.9×	65 3.6×	17	145
Dennis Mauricio United States	3	23 0.5×	33 1.2×	18 0.9×	13 0.7×	36 2.0×	6	92
Angela Jain United States	4	20 0.4×	15 0.5×	4 0.2×	35 1.8×	23 1.3×	14	68
A. Casado Herráez Spain	5	21 0.4×	23 0.8×	9 0.5×	21 1.1×	26 1.4×	11	70
Christel M. Davis United States	7	152 3.0×	9 0.3×	11 0.6×	3 0.2×	26 1.4×	12	203

Countries citing papers authored by M H Yu

Since Specialization

Citations

This map shows the geographic impact of M H Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M H Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M H Yu more than expected).

Fields of papers citing papers by M H Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M H Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M H Yu. The network helps show where M H Yu may publish in the future.

Co-authorship network of co-authors of M H Yu

This figure shows the co-authorship network connecting the top 25 collaborators of M H Yu. A scholar is included among the top collaborators of M H Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M H Yu. M H Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Hu, Lina, et al.. (2021). Prognostic role of MUC-2 expression in patients with gastric carcinoma: a systematic review and meta-analysis. SHILAP Revista de lepidopterología. 1 indexed citations

Yu, M H, et al.. (2010). Chemotherapy with low-dose bevacizumab and carboplatin in the treatment of a patient with recurrent cervical cancer.. PubMed. 31(3). 350–3. 8 indexed citations

Lin, Ching‐Yu, et al.. (2006). Plasma proteomic profiling for detecting and differentiating in situ and invasive carcinomas of the uterine cervix. International Journal of Gynecological Cancer. 16(3). 1216–1224. 20 indexed citations

Lin, Ya‐Wen, et al.. (2006). Plasma proteomic pattern as biomarkers for ovarian cancer. International Journal of Gynecological Cancer. 16. 139–146. 10 indexed citations

Chen, Chun‐Chi, et al.. (2005). Conservative therapy of stage I endometrial adenocarcinoma and atypical endometrial hyperplasia for the preservation of fertility. International Journal of Gynecology & Obstetrics. 92(2). 137–138. 9 indexed citations

Chu, Tang‐Yuan, et al.. (2002). A research-based tumor tissue bank of gynecologic oncology: characteristics of nucleic acids extracted from normal and tumor tissues from different sites. International Journal of Gynecological Cancer. 12(2). 171–176. 8 indexed citations

Kao, M.S., et al.. (2000). Elevated Topoisomerase I Activity in Cervical Cancer as a Target for Chemoradiation Therapy. Gynecologic Oncology. 79(2). 272–280. 15 indexed citations

Huang, Wentao, et al.. (2000). Effects of temperature on radiochemical purity and immunoreactivity of radiolabeled monoclonal antibody 1H10.. PubMed. 28(3). 182–5. 1 indexed citations

Yu, M H, et al.. (2000). Verrucous carcinoma of the uterine cervix.. PubMed. 63(10). 765–9. 4 indexed citations

10.

Chang, Y.‐K., et al.. (1998). Extra-amniotic balloon with PGE₂versus extra-ovular Foley catheter with PGF_2αin mid-trimester pregnancy termination. International Journal of Gynecology & Obstetrics. 63(1). 51–54. 2 indexed citations

11.

Lee, Sang Chul, et al.. (1997). Genetically engineered human interleukin-6 variant with enhanced stability. Biotechnology Letters. 19(9). 885–888. 1 indexed citations

12.

Yu, M H, et al.. (1995). HERNIA UTERUS INGUINALE ASSOCIATED WITH UNILATERAL RENAL AGENESIS. Australian and New Zealand Journal of Surgery. 65(9). 688–690. 10 indexed citations

13.

Roffler, Steve R., et al.. (1992). Characterization of a human cervical carcinoma-associated antigen by lectin binding and immuno-electron microscopy. Histochemistry and Cell Biology. 97(6). 453–461. 1 indexed citations

14.

Roffler, Steve R., et al.. (1991). New monoclonal antibody against human cervical carcinoma with diagnostic and therapeutic potential.. PubMed. 24(1). 19–29. 6 indexed citations

15.

Roffler, Steve R., et al.. (1991). Therapy of human cervical carcinoma with monoclonal antibody-Pseudomonas exotoxin conjugates.. PubMed. 51(15). 4001–7. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact